Replies to post #785183 on NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

ReL Lykiri post 785181
There is a new authorisation date for Advent BioServices’ MIA(IMP) licence UK MIA(IMP) 54923.
The latest authorisation is dated 21 August 2025, while the previous one was 20 December 2024 – a relatively short interval between updates.
https://cms.mhra.gov.uk/mhra/mia/uk-miaimp-54923

The new authorisation (21 Aug 2025) extends Advent’s licence beyond manufacturing: it now also covers importation of investigational medicinal products (including cell therapy/live cell products) and QP-certified IMPs from approved countries.

and your post #785183
Lykiri The question is why the recent update. This is not the norm.???

Here is a gov.uk link to"
"Guidance - Importing investigational medicinal products (IMP) from countries on a list to Great Britain
Updated 12 February 2025"

https://www.gov.uk/government/publications/importing-investigational-medicinal-products-into-great-britain-from-approved-countries/importing-investigational-medicinal-products-imp-from-countries-on-a-list-to-great-britain